PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Jan-2025 NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 AccessWire
13-Jan-2025 Frontage Announces Co-CEO Promotions AccessWire
13-Jan-2025 Teva becomes strategic commercialization partner for Formycon’s biosimilar candidate FYB203 (Eylea®/ aflibercept) in major parts of Europe and Israel Formycon AG
13-Jan-2025 Genflow Biosciences PLC Announces Holding(s) in Company - 2 AccessWire
13-Jan-2025 Genflow Biosciences PLC Announces Holding(s) in Company - 1 AccessWire
10-Jan-2025 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management Changes AccessWire
10-Jan-2025 Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AccessWire
10-Jan-2025 Pace(R) Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025 Newswire
10-Jan-2025 New Clevorx Cold Sore Treatment Cream Offers Relief and Comfort Newswire
10-Jan-2025 Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3 Tiziana Life Sciences
10-Jan-2025 iTeos Announces 2025 Strategic Priorities and Anticipated Milestones iTeos Therapeutics
10-Jan-2025 PharmD On Demand + 340B AccessWire
10-Jan-2025 SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 SYNBIOTIC SE
10-Jan-2025 Aston University researchers seek participants for newly funded study into medication weight gain Aston University
10-Jan-2025 Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations ZAGENO
10-Jan-2025 MitoRx Therapeutics Expands Leadership Team with Strategic Appointments of Chief Business Officer and Finance Director MitoRx Therapeutics
10-Jan-2025 David Schilansky Appointed Chief Financial Officer of Ariceum Therapeutics Ariceum Therapeutics
10-Jan-2025 Cytosurge Announces Strategic Leadership Transition Cytosurge AG
10-Jan-2025 Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology Synaffix B.V.
10-Jan-2025 Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics Oxford BioTherapeutics (OBT)